CW
BMY icon

CreativeOne Wealth’s Bristol-Myers Squibb BMY Stock Holding History

CreativeOne Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83M Sell
30,184
-678
-2% -$39.5K 0.04% 378
2025
Q4 		$1.66M Sell
30,862
-3,018
-9% -$145K 0.04% 381
2025
Q3 		$1.53M Sell
33,880
-1,378
-4% -$64.4K 0.04% 402
2025
Q2 		$1.63M Buy
35,258
+2,510
+8% +$123K 0.04% 395
2025
Q1 		$2M Buy
32,748
+1,969
+6% +$115K 0.06% 306
2024
Q4 		$1.74M Sell
30,779
-2,913
-9% -$163K 0.05% 321
2024
Q3 		$1.74M Buy
33,692
+7,272
+28% +$341K 0.06% 297
2024
Q2 		$1.1M Sell
26,420
-2,116
-7% -$94.7K 0.06% 306
2024
Q1 		$1.55M Buy
28,536
+10,709
+60% +$546K 0.06% 279
2023
Q4 		$915K Buy
17,827
+4,592
+35% +$241K 0.06% 265
2023
Q3 		$768K Sell
13,235
-4,609
-26% -$282K 0.06% 272
2023
Q2 		$1.14M Buy
17,844
+29
+0.2% +$1.95K 0.05% 309
2023
Q1 		$1.24M Sell
17,815
-704
-4% -$49.7K 0.06% 266
2022
Q4 		$1.33M Buy
18,519
+1,928
+12% +$145K 0.07% 240
2022
Q3 		$1.18M Buy
16,591
+109
+0.7% +$7.91K 0.07% 235
2022
Q2 		$1.27M Sell
16,482
-258
-2% -$19.6K 0.07% 220
2022
Q1 		$1.22M Buy
16,740
+1,543
+10% +$104K 0.06% 247
2021
Q4 		$948K Buy
15,197
+2,481
+20% +$146K 0.05% 296
2021
Q3 		$752K Buy
12,716
+221
+2% +$14.6K 0.04% 306
2021
Q2 		$835K Buy
12,495
+3,593
+40% +$234K 0.05% 281
2021
Q1 		$562K Sell
8,902
-528
-6% -$32.9K 0.04% 310
2020
Q4 		$585K Buy
9,430
+4,948
+110% +$304K 0.05% 263
2020
Q3 		$270K Buy
4,482
+9
+0.2% +$542 0.04% 222
2020
Q2 		$263K Buy
4,473
+12
+0.3% +$718 0.04% 205
2020
Q1 		$248K Sell
4,461
-335
-7% -$20.5K 0.05% 174
2019
Q4 		$308K Sell
4,796
-581
-11% -$33.3K 0.05% 162
2019
Q3 		$272K Sell
5,377
-118
-2% -$5.55K 0.05% 145
2019
Q2 		$249K Buy
+5,495
New +$256K 0.05% 149

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CreativeOne Wealth's BMY Position: Q1 2026 in Review

CreativeOne Wealth reduced its Bristol-Myers Squibb (BMY) stake by 2.2% in Q1 2026, selling an estimated $39.5K and leaving 30,184 shares worth $1.83M. The position accounts for 0.04% of the portfolio, ranked #378.

CreativeOne Wealth first reported a position in BMY in Q2 2019 and has held it in 28 quarters since. The position peaked at $2M in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • CreativeOne Wealth held 30,184 shares of Bristol-Myers Squibb worth $1.83M as of Q1 2026.
  • CreativeOne Wealth sold 678 Bristol-Myers Squibb shares in Q1 2026, an estimated $39.5K.
  • Bristol-Myers Squibb made up 0.04% of CreativeOne Wealth's portfolio in Q1 2026, its #378 holding.
  • CreativeOne Wealth first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 28 quarters since.
  • CreativeOne Wealth's Bristol-Myers Squibb position peaked at $2M in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.